OUR PURPOSE Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies. OUR CREDENTIALS Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016. With additional operations in the Netherlands and the USA, we continue to grow our global team. To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing. Kuros is an innovative global company with: - Listing on the SIX Swiss Exchange under the symbol KURN - A commercial & research footprint that spans >20 markets - 4 teams of internationally renowned clinical and scientific expert advisers - >25 orthobiologics-related patents - >400 patients evaluated in Level I, randomized controlled clinical trials - 10 well-controlled Level I-III clinical trials initiated, including 6 that are complete CONTACT KUROS TO FIND OUT MORE >>>>